Cargando…
Pension and state funds dominating biomedical R&D investment: fiduciary duty and public health
BACKGROUND: Who benefits from the commercial biomedical research and development (R&D)? Patients-consumers and investors-shareholders have traditionally been viewed as two distinct groups with conflicting interests: shareholders seek maximum profits, patients - maximum clinical benefit. However,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833262/ https://www.ncbi.nlm.nih.gov/pubmed/31690328 http://dx.doi.org/10.1186/s12992-019-0490-x |